Navigating perimenopause often feels like an uphill battle. Hormonal shifts during this phase can make weight gain, fatigue, and changes in overall well-being more challenging. If you’re a woman searching for effective weight management options, Wegovy (semaglutide) might be a powerful tool to consider. Let’s explore how Wegovy works, its potential hormonal impact, and how it can support women during perimenopause.

What is Wegovy?

Wegovy is an FDA-approved medication specifically designed for weight management. It contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone in your body. By targeting areas in the brain that regulate appetite and digestion, Wegovy helps reduce hunger, increase satiety, and support sustainable weight loss.

How Hormonal Changes During Perimenopause Affect Weight

Perimenopause is marked by fluctuating levels of estrogen and progesterone, which can slow metabolism and increase fat storage, particularly around the abdomen. Additionally, hormonal imbalances can lead to:

• Increased Appetite: Changing hormone levels can trigger cravings and overeating.
• Slower Metabolism: Reduced estrogen levels often cause the body to burn fewer calories.
• Weight Redistribution: Fat tends to accumulate in areas like the waistline.

These shifts make traditional weight-loss methods more challenging, and that’s where Wegovy can help.

How Wegovy Supports Weight Management During Perimenopause

Wegovy’s mechanism of action aligns well with the challenges perimenopausal women face. Here’s how it works: